Edwards Lifesciences Corporatio

Historical 13F Holders

Symbol
EW
CUSIP
28176E108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 28176E108 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Capital Management LLC 13G 7.5% 4/29/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 7.5% 10/17/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Wellington Management Group LLP 13G/A
3.4% 8/12/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 147 18.8 M $1.62 B
2026 Q2 1,388 605 M $48.2 B
2026 Q1 1,352 504 M $40.4 B
2025 Q4 1,379 507 M $43.2 B
2025 Q3 1,335 525 M $40.8 B
2025 Q2 1,327 506 M $39.5 B
2025 Q1 1,275 506 M $36.7 B
2024 Q4 1,307 503 M $37.2 B
2024 Q3 1,284 492 M $32.4 B
2024 Q2 1,369 510 M $47.0 B
2024 Q1 1,351 512 M $48.8 B
2023 Q4 1,314 502 M $38.4 B
2023 Q3 1,290 495 M $34.3 B
2023 Q2 1,341 497 M $46.9 B
2023 Q1 1,308 499 M $41.2 B
2022 Q4 1,291 536 M $40.5 B
2022 Q3 1,309 518 M $42.8 B
2022 Q2 1,322 512 M $48.6 B
2022 Q1 1,361 511 M $60.0 B
2021 Q4 1,373 517 M $66.9 B
2021 Q3 1,279 514 M $58.2 B
2021 Q2 1,243 514 M $53.3 B
2021 Q1 1,185 510 M $42.7 B
2020 Q4 1,223 531 M $49.3 B
2020 Q3 1,134 517 M $41.2 B
2020 Q2 1,098 509 M $35.2 B
2020 Q1 1,071 172 M $32.4 B
2019 Q4 1,152 177 M $41.2 B
2019 Q3 1,024 174 M $38.1 B
2019 Q2 988 174 M $32.2 B
2019 Q1 981 176 M $33.6 B
2018 Q4 919 180 M $27.6 B
2018 Q3 908 184 M $32.0 B
2018 Q2 884 178 M $25.9 B
2018 Q1 857 175 M $24.4 B
2017 Q4 816 176 M $19.9 B
2017 Q3 773 177 M $19.3 B
2017 Q2 761 176 M $20.8 B
2017 Q1 730 178 M $16.8 B
2016 Q4 734 182 M $17.1 B
2016 Q3 729 180 M $21.7 B
2016 Q2 732 179 M $18.4 B
2016 Q1 701 186 M $16.0 B
2015 Q4 640 185 M $14.8 B
2015 Q3 599 89.3 M $12.7 B
2015 Q2 607 85.2 M $12.1 B
2015 Q1 599 91.1 M $13.0 B
2014 Q4 588 92.8 M $11.8 B
2014 Q3 523 92.4 M $9.47 B
2014 Q2 453 95.3 M $8.18 B
2014 Q1 444 97.7 M $7.25 B